{"id":409743,"date":"2025-09-09T06:26:11","date_gmt":"2025-09-09T06:26:11","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/409743\/"},"modified":"2025-09-09T06:26:11","modified_gmt":"2025-09-09T06:26:11","slug":"state-govt-exploring-whether-pharmacists-should-prescribe-flu-antivirals","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/409743\/","title":{"rendered":"State Govt &#8216;exploring&#8217; whether pharmacists should prescribe flu antivirals"},"content":{"rendered":"<p>The NSW Government could let pharmacists prescribe S4 antivirals for influenza, having already locked in pharmacist diagnosis and treatment of impetigo, shingles, dermatitis and psoriasis.<\/p>\n<p>Despite not expecting to receive an evaluation report until 2026, NSW Premier Chris Minns announced on Friday that a 12-month pilot of pharmacists treating skin conditions with S4 drugs would become business as usual (see medicines list below).<\/p>\n<p>\u201cThis is an important part of our work to build a fairer system for the people of NSW, removing red tape and making it much simpler to access medications,\u201d Mr Minns said.<\/p>\n<p>\u201cBy enabling pharmacists to help manage common conditions, we are increasing access to care and relieving pressure on our GPs and the public hospital system.\u201d<\/p>\n<p>\t\t\u00d7<\/p>\n<p>\n\t\t\t\tSign in\n\t\t\t<\/p>\n<p class=\"message adg-password-reset\">\n\t\t\t\tIf this is your first visit to the new AusDoc website, reset your password<br \/>\n\t\t\t\t<a class=\"adg-reset_password_link\" href=\"https:\/\/www.ausdoc.com.au\/wp-login.php?action=lostpassword\" target=\"_blank\" rel=\"noopener\">here.<\/a>\n\t\t\t<\/p>\n","protected":false},"excerpt":{"rendered":"The NSW Government could let pharmacists prescribe S4 antivirals for influenza, having already locked in pharmacist diagnosis and&hellip;\n","protected":false},"author":2,"featured_media":409744,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[141008,6439,114276,1234,105,6552,141009,4326,12,51527,141010,7398,90669,26331,141011,141012,7395,16,15],"class_list":{"0":"post-409743","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-antiviral","9":"tag-dermatology","10":"tag-general-practice","11":"tag-government","12":"tag-health","13":"tag-infectious-diseases","14":"tag-influenza-flu","15":"tag-medication","16":"tag-news","17":"tag-nsw","18":"tag-pharmacist-prescribing","19":"tag-pharmacists","20":"tag-pharmacology","21":"tag-pharmacy","22":"tag-pharmacy-guild-of-australia","23":"tag-pharmacy-pilot","24":"tag-prescribing","25":"tag-uk","26":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115172919644971857","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/409743","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=409743"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/409743\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/409744"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=409743"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=409743"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=409743"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}